UAE News Online
Main » 2015 » September » 26
INGELHEIM, Germany - Friday, September 25th 2015 [ME NewsWire] First specific reversal agent for a non-vitamin K antagonist oral anticoagulant (NOAC) to gain CHMP positive opinion1 Positive opinion is based on clinical trial results which showed that idarucizumab reverses the anticoagulant effect of dabigatran within minutes2-4 (BUSINESS WIRE)-- Today, the Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending European approval of idarucizumab (to be marketed as Praxbind®).1 Idarucizumab is intended for use in adult patients treated with Pradaxa® (dabigatran etexilate) when rapid reversal of its anticoagulant effects is required for emergency surgery / urgent procedures or in life-threatening or uncontrolled bleeding.1 “The CHMP positive opinion in favour of idarucizumab approval is an important recommendation in the field of anticoagulation care,” said Professor Fausto J. Pinto, University of Lisbon, ... Read more »
Views: 93 | Added by: uaeonlinenews | Date: 09.26.2015 | Comments (0)

ROLLING MEADOWS, Illinois - Samedi 26 Septembre 2015 [ME NewsWire] (BUSINESS WIRE)--Une enquête auprès de 900 experts de la cybersécurité montre que l'écrasante majorité des experts (87 %) anticipent une augmentation des violations de données des paiements mobiles au cours des 12 prochains mois, et pourtant 42 % d'entre eux ont utilisé ce moyen de paiement en 2015. L'Étude sur la sécurité des paiements mobiles 2015 de l'association sur la cybersécurité mondiale ISACA suggère que les professionnels de la cybersécurité sont prêts à concilier les avantages et les risques de sécurité présumés des paiements mobiles : Seulement 23 % pensent que les paiements mobiles sont sûrs quand il s'agit de maintenir la sécurité des informations personnelles. Près de la moitié (47 %) disent que les paiements mobiles ne sont pas sûrs. À 89 %, les espèces étaient considérées comme le moyen de paiement le plus sûr, mais seulement 9 % préfèrent l'utiliser. « Les paiements mobiles représentent la derniè ... Read more »
Views: 98 | Added by: uaeonlinenews | Date: 09.26.2015

ROLLING MEADOWS, Ill. - Thursday, September 24th 2015 [ME NewsWire] (BUSINESS WIRE)-- A survey of 900 cybersecurity experts shows an overwhelming majority (87%) expect an increase in mobile payment data breaches over the next 12 months, yet 42% have used this payment method in 2015. The 2015 Mobile Payment Security Study from global cybersecurity association ISACA suggests that cybersecurity professionals are willing to balance benefits with perceived security risks of mobile payments: Only 23% believe that mobile payments are secure in keeping personal information safe. Nearly half (47%) say mobile payments are not secure. At 89%, cash was deemed the most secure payment method, but only 9% prefer to use it. “Mobile payments represent the latest frontier for the choice we make to balance security and privacy risk and convenience,” said John Pironti, risk advisor with ISACA and president of IP Architects. “ISACA members, who are some of the most cyber-aware professionals in the wo ... Read more »
Views: 106 | Added by: uaeonlinenews | Date: 09.26.2015

FALLS CHURCH, Va - Monday, September 21st 2015 [ME NewsWire] (BUSINESS WIRE)-- CSC (NYSE: CSC), a global leader in next-generation IT services and solutions, today announced it has closed the acquisition of Fruition Partners, the leading provider of technology-enabled solutions for the service-management sector and the largest ServiceNow-exclusive service-management consulting firm. The acquisition bolsters CSC’s ability to offer enterprise and emerging clients an expanded range of cloud-based service-management solutions to improve their business results through organizational efficiency and lower operating costs. Fruition Partners is now a wholly owned subsidiary of CSC and will do business as Fruition Partners, a CSC company. Financial terms of the transaction were not disclosed. ServiceNow is a CSC strategic alliance partner. Combining Fruition Partners with the scale, reach, industry penetration and extensive skill portfolio of CSC creates an extraordinary leadership position i ... Read more »
Views: 87 | Added by: africa-live | Date: 09.26.2015

RESTON, Va. - Thursday, September 24th 2015 [ME NewsWire] (BUSINESS WIRE)-- Global satellite solutions provider SES Government Solutions (SES GS) will support the Federal Aviation Administration’s (FAA) Wide Area Augmentation System (WAAS) on the ground as well as in space. On 31 August 2015, Raytheon Integrated Defense Systems announced its selection of SES GS to build two GEO Uplink Subsystem stations to support the next generation of the WAAS network. The data transmitted by the uplink stations will improve the accuracy, integrity and availability of the GPS signals intended to enable aircraft to rely on GPS for all phases of flight, including precision approaches to airports within the coverage area. “SES GS is proud to expand our partnership with Raytheon and the FAA beyond the SES-15 hosted payload to include development, delivery and operations of the ground uplink stations,” said Corporate Vice President of Development, Tim Deaver. SES GS was awarded the contract to include ... Read more »
Views: 106 | Added by: uaeonlinenews | Date: 09.26.2015

BOUDRY, Switzerland - Friday, September 25th 2015 [ME NewsWire] Anticipated approval could provide new option for population with limited treatments Expanded indication brings medicine to elderly AML patients who are not eligible for haematopoietic stem cell transplantation and who have >30% myeloblasts in their bone marrow (BUSINESS WIRE)-- Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an expanded indication of VIDAZA® (azacitidine for injection) for the treatment of adult patients aged 65 years or older with acute myeloid leukaemia (AML) who are not eligible for haematopoietic stem cell transplantation (HSCT). The expanded indication now covers patients who have >30% myeloblasts according to the WHO classification; previously, the indication covered AML patients with <30% blasts. Mye ... Read more »
Views: 103 | Added by: uaeonlinenews | Date: 09.26.2015 | Comments (0)